Craig S. Atwood, PhD, University of Western Australia,1993
Affiliations: | Medicine | University of Wisconsin, Madison, Madison, WI |
Area:
Alzheimer disease and AgingWebsite:
http://agingresearch.wisc.edu/atwood.htmGoogle:
"Craig Atwood"Bio:
http://www2.medicine.wisc.edu/home/people-search/people/staff/2701/ATWOOD_CRAIG_S
Cross-listing: Neurotree - Neuropathology Tree
Parents
Sign in to add mentor| Ashley I. Bush | post-doc | 1995-2000 | Harvard Medical School and Massachusetts General Hospital |
| George Perry | research scientist | Case Western |
Children
Sign in to add trainee| Kentaro Hayashi | grad student | 2008- | UW Madison (Neurotree) |
| Miguel Gallego | grad student | 2005-2007 | (Neurotree) |
| Prashob Porayette | grad student | 2006-2007 | UW Madison (Neurotree) |
| Andrea C. Wilson | grad student | 2003-2009 | UW Madison (Neurotree) |
| Glenda M. Bishop | post-doc | 2002-2003 | Case Western (Neurotree) |
| Giuseppe Verdile | post-doc | 2002-2004 | Edith Cowan University |
| Prashob Porayette | post-doc | 2007-2008 | UW Madison (Neurotree) |
| Sivan Vadakkadath Meethal | research scientist | 2003-2010 | UW Madison (Neurotree) |
Collaborators
Sign in to add collaborator| Richard L. Bowen | collaborator | Voyager Pharmaceuticals | |
| Mark Anthony Smith | collaborator | Case Western |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Butler T, Goldberg JD, Galvin JE, et al. (2021) Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus cholinesterase inhibition to reduce neurologic decline in Alzheimer's. Contemporary Clinical Trials. 106488 |
| Hayashi K, Gonzales TK, Kapoor A, et al. (2020) Development of Classification Models for the Prediction of Alzheimer's Disease Utilizing Circulating Sex Hormone Ratios. Journal of Alzheimer's Disease : Jad |
| Kunkle BW, Grenier-Boley B, Sims R, et al. (2019) Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics |
| Kunkle BW, Grenier-Boley B, Sims R, et al. (2019) Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. 51: 414-430 |
| Butler T, Bowen R, Atwood CS. (2019) Septal hypertrophy and cell cycle re-entry in AD. Aging |
| Atwood CS, Ekstein SF. (2018) Human versus non-human sex steroid use in hormone replacement therapies part 1: Preclinical data. Molecular and Cellular Endocrinology |
| Smith MA, Bowen RL, Nguyen RQ, et al. (2018) Putative Gonadotropin Releasing Hormone Agonist Therapy and Dementia: An Application of Medicare Hospitalization Claims Data. Journal of Alzheimer's Disease : Jad |
| Geddes RI, Hayashi K, Bongers Q, et al. (2017) Correction: Conjugated Linoleic Acid Administration Induces Amnesia in Male Sprague Dawley Rats and Exacerbates Recovery from Functional Deficits Induced by a Controlled Cortical Impact Injury. Plos One. 12: e0188611 |
| Sims R, van der Lee SJ, Naj AC, et al. (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics |
| Atwood CS, Hayashi K, Meethal SV, et al. (2017) Does the degree of endocrine dyscrasia post-reproduction dictate post-reproductive lifespan? Lessons from semelparous and iteroparous species. Geroscience |